Matthew K Szot
CFO at Cadrenal Therapeutics, Inc. (CVKD); Director at INVO Fertility, Inc. (IVF); Director at SenesTech, Inc. (SNES)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $195K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 31SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 9,933 | $6.97 | $69K | -86.9% |
| Dec 5SEC | IVFINVO Fertility, Inc. | Sell | 43 held (−57%) | $1.52 | $6 | -52.1% |
| Nov 17SEC | SNESSenesTech, Inc. | Sell | 1 | $2.75 | $3 | -75.6% |
| Oct 28SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 1,80011,733 held (−13%) | $13.99 | $25K | -93.5% |
| Oct 28SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 1,8009,933 held (−15%) | $13.99 | $25K | -93.5% |
| Oct 14SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 1,69315,333 held (−10%) | $13.99 | $24K | -93.5% |
| Oct 14SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 1,80013,533 held (−12%) | $14.07 | $25K | -93.5% |
| Oct 7SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 10717,026 held (−1%) | $13.99 | $1K | -93.5% |
| Oct 1SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 10018,833 held (−1%) | $14.00 | $1K | -93.5% |
| Oct 1SEC | CVKDCadrenal Therapeutics, Inc. | Sell Plan | 1,70017,133 held (−9%) | $13.99 | $24K | -93.5% |
- Sell
CFO Matthew K Szot sold $69K of CVKD at $6.97 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Matthew K Szot sold $6 of IVF at $1.52 — cuts the stake by 57%.
- Sell
CFO Matthew K Szot sold $25K of CVKD at $13.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthew K Szot sold $25K of CVKD at $13.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthew K Szot sold $24K of CVKD at $13.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthew K Szot sold $25K of CVKD at $14.07 — pre-scheduled 10b5-1 plan sale.